Fundraising FoxEvicure
2 known investors
Find your way into Evicure
Sign up to see every warm intro you have to Evicure
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Evicure team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EviCure is a pre-clinical biopharmaceutical company developing extracellular vesicle-based therapies for cancer treatment using AI and disease modeling. The company uses AI-powered platforms to identify EV subpopulations with therapeutic potential and enables targeted drug delivery for oncology applications.
Founders & leadership
EJ
Eric J. MessikaCEOEric J. Messika is CEO of EviCure, which develops extracellular vesicle-based therapies for cancer using AI and disease modeling platforms. He previously served as President and CEO of Coronis Neurosciences and has over a decade of executive leadership experience in biotech drug development.
AB
Aharon BrodieCTO
CB
Chaya BrodieConsultant
Investors · 2
Frequently asked questions
- What does Evicure do?
- EviCure is a pre-clinical biopharmaceutical company developing extracellular vesicle-based therapies for cancer treatment using AI and disease modeling. The company uses AI-powered platforms to identify EV subpopulations with therapeutic potential and enables targeted drug delivery for oncology applications.
- Who are Evicure's investors?
- Evicure's investors include Incentive, Peregrine Ventures Incubator, Peregrine Ventures.